3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Small Cell Lung Carcinoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Mesothelioma
1
Medulloblastoma
1
Familial ependymoma
1
Fallopian Tube Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Astrocytoma
1
Interventions
Carboplatin
103
Pemetrexed
96
pembrolizumab
78
Docetaxel
78
Cisplatin
72
Paclitaxel
70
Erlotinib Hydrochloride
50
Gemcitabine
48
Radiotherapy
42
Nivolumab
35
Bevacizumab
35
atezolizumab
25
Radiosurgery
24
durvalumab
20
Cyclophosphamide
17
130-nm albumin-bound paclitaxel
15
Vinorelbine
14
Taxes
14
Radiation
14
Etoposide
13
Ipilimumab
12
Albumin-Bound Paclitaxel
12
avelumab
11
Drug Therapy
10
Cetuximab
10
spartalizumab
9
Sorafenib
9
trametinib
8
osimertinib
8
capmatinib
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma, Non-Small-Cell Lung
×
Acetylcysteine
×
Clear all
NCT00637624
2022-08-25
NAC-PNP
Rijnstate Hospital
Phase NA
Terminated
69 enrolled